This compound is primarily utilized in the pharmaceutical industry as a key chiral intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral structure makes it valuable in the production of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the development of medications for neurological disorders, such as epilepsy and chronic pain, where the resulting APIs interact with specific receptors in the brain. Additionally, its diphenyl moiety contributes to the creation of compounds with enhanced binding affinity and selectivity, making it a crucial component in drug discovery and development processes.